AKT1 and cancer: The KEGG enrichment analysis showed that galangin can mainly affect 37 signaling pathways, including the cell cycle, pathways in cancer, the PI3K-Akt signaling pathway, microRNAs in cancer, and chemical carcinogenesis - receptor activation.